Success Metrics

Clinical Success Rate

91.2%

Based on 31 completed trials

Completion Rate

91%(31/34)

Active Trials

7(14%)

Results Posted

65%(20 trials)

Terminated

3(6%)

Phase Distribution

Ph phase_2

14%

Ph phase_1

26%

Ph phase_3

20%

Ph not_applicable

Ph phase_4

26%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution47 total trials

Phase 1Safety & dosage

13(27.7%)

Phase 2Efficacy & side effects

7(14.9%)

Phase 3Large-scale testing

10(21.3%)

Phase 4Post-market surveillance

13(27.7%)

N/ANon-phased studies

4(8.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.2%

31 of 34 finished

Non-Completion Rate

8.8%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(8)

Completed(31)

Terminated(3)

Other(8)

Detailed Status

Completed31

unknown8

Recruiting7

Terminated3

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

91.2%

Most Advanced

Phase 4

Trials by Phase

Phase 113 (27.7%)

Phase 27 (14.9%)

Phase 310 (21.3%)

Phase 413 (27.7%)

N/A4 (8.5%)

Trials by Status

recruiting714%

completed3162%

not_yet_recruiting12%

terminated36%

unknown816%

Recent Activity

7 active trials

Showing 5 of 50

not_yet_recruitingphase_1

Study of ECC4703 With Sulfasalazine and Pitavastatin

NCT07726368

recruitingphase_2

Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty

NCT07138898

recruitingphase_2

Clinical Trials (50)

Showing 20 of 50 trialsScroll for more

NCT07726368Phase 1

Study of ECC4703 With Sulfasalazine and Pitavastatin

Not Yet Recruiting

NCT07138898Phase 2

Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty

Recruiting

NCT05703425Phase 2

The Effect of Sulfasalazine on CRH Levels in Pregnant Women

Recruiting

NCT03414502Phase 3

Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response

Recruiting

NCT03561584Phase 2

Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis

Completed

NCT03739853Phase 4

Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial

Completed

NCT03254589Phase 4

Methotrexate, Blood Pressure and Arterial Function in Rheumatoid Arthritis

Completed

NCT03847311Phase 2

Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients

Completed

NCT04720183Phase 1

Drug-drug Interaction Study with GLPG3970 and Sulfasalazine in Adult, Healthy Subjects

Completed

NCT04725422

CHronic Nonbacterial Osteomyelitis International Registry

Recruiting

NCT02451748Phase 4

IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA

Completed

NCT05580861Phase 1

Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment

Recruiting

NCT05664464Phase 1

Glutamate Inhibitors in Glioblastoma

Recruiting

NCT06134388Phase 3

Sulfasalazine in Patients With Metastatic Colorectal Cancer

Recruiting

NCT04205357Phase 1

Sulfasalazine and Stereotactic Radiosurgery for Recurrent Glioblastoma

Completed

NCT05445440Phase 1

A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Sulfasalazine

Completed

NCT04610476Phase 3

Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis

Unknown

NCT02374021Phase 4

Treatments Against RA and Effect on FDG-PET/CT

Completed

NCT03440892

Effects of Antirheumatic Treatment on Levels of Survivin in Rheumatoid Arthritis Patients

Unknown

NCT03449758Phase 4

Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis

Completed

Drug Details

Intervention Type: DRUG
Total Trials: 50